Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT01199081
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 154 participants
- Sponsor
- Registry
-
NCT01199081 -
2010-019247-19
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Colombia, Czechia, Denmark, France, Germany, Mexico, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01199081. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
- Acronym
- ARTEMIS AF LT
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Dronedarone
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01199081- Content hash
6cd8e8df4d3a1ab659a2782d73c77a7c4ff77af6245c5d857e9ad53e59d13c32